Tag: Recro Pharma

Exton-based Recro Pharma has acquired its West Coast competitor, Irisys of San Diego, in a cash and stock deal valued at roughly $50 million…

Malvern-based Recro Pharma has named David Enloe its new president and CEO, writes John George for the Philadelphia Business Journal.

Enloe replaces the company…

Malvern-based Recro Pharma saw its stock plunge by more than 34 percent after the Food and Drug Administration rejected its new drug application for…

Recro Pharma’s stock took a major hit after the FDA rejected a new drug application for the Malvern company’s non-opioid pain medication…

Malvern’s Recro Pharma has secured a line of credit worth $100 million from funds managed by Athyrium Capital Management, writes John George for the…

Recro Pharma is injecting some new prospects into its effort to alleviate surgical patients’ pain without the use of addictive opioids.

The Malvern pharmaceutical company…

DNB Financial Corporation, the parent of DNB First, and Malvern’s Recro Pharma, a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and…

Malvern’s Recro Pharma is already preparing for the potential commercial launch of its highly anticipated new drug with a $35.9 million public stock…

Recro Pharma’s latest drug test felt more like a shot of adrenaline than a sigh of relief when patients noted they were well aware…

The Ideas x Innovation Network (i2n) is a program within the Chester County Economic Development Council (CCEDC). The mission of i2n is to support emerging…

Malvern’s Recro Pharma is looking to raise $15 million through a public stock offering. Most of the funds are earmarked for ongoing late stage…

VISTA Today Daily News Business Briefs are concise stories that bring you up to date with what’s going on around Chester County.

UTC and…

Chester County business daily news briefs review yesterday’s business stories important to Chester County and beyond.

Vanguard Group Sides With duPont’s Management, Fends…

Chester County Daily News Business Briefs are short summaries and links to important Chester County’s business stories not included in VISTA Today’s daily…

The promise of bringing pain relief to patients right out of surgery without using narcotics is another step closer to reality for a Malvern specialty…

Recro Pharma Inc. (NASDAQ:REPH) released its fourth quarter and full year financial results for the period ending December 31, 2014 last month. The clinical…

Recro Pharma, Inc., a specialty pharmaceutical firm with offices in Malvern and Ireland, is purchasing a Georgia manufacturing facility from Alkermes PLC and global rights…

Major shareholders and leaders inside a Malvern non-opioid pain therapeutics pharmaceutical company may show their hand concerning the firm’s future, now that Recro…